Literature DB >> 12587125

Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs.

Greg A Kossena1, Ben J Boyd, Christopher J H Porter, William N Charman.   

Abstract

Colloidal mixtures containing bile salts (BS), phosphatidylcholine (PC), and medium and long-chain monoglycerides and fatty acids were prepared as model systems to represent typical intestinal contents after digestion of formulation derived lipids under both low (5 mM BS/1.25 mM PC) and high (20 mM BS/5 mM PC) BS and PC conditions. Size-exclusion chromatography of the colloidal species that formed in the medium-chain digests indicated the presence of vesicles, mixed micelles, and simple micelles, whereas the long-chain digests contained only vesicles and mixed micelles. In the long-chain digests the mixed micellar phase was the predominant drug solubilizing species for griseofulvin, danazol, and halofantrine, although for increasingly lipophilic drugs, the vesicular phase contributed an increasing proportion of the solubilization capacity. In contrast, the solubilization capacity of the vesicular phase was predominant in the medium-chain digests, and no clear trends were evident in the relationship between drug lipophilicity and proportional solubilization. These data highlight the need to consider the colloidal species that form in the small intestine during the digestion of common formulation lipids and the coincident enhancement in drug solubilization provided under these circumstances. Copyright 2003 Wiley-Liss, Inc. and the American Pharmaceutical Association

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12587125     DOI: 10.1002/jps.10329

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  30 in total

1.  Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs.

Authors:  Jean F Cuiné; William N Charman; Colin W Pouton; Glenn A Edwards; Christopher J H Porter
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

2.  Postprandial changes in solubilizing capacity of human intestinal fluids for BCS class II drugs.

Authors:  Sarah Clarysse; Dimitrios Psachoulias; Joachim Brouwers; Jan Tack; Pieter Annaert; Guus Duchateau; Christos Reppas; Patrick Augustijns
Journal:  Pharm Res       Date:  2009-03-07       Impact factor: 4.200

3.  Colloidal structures in media simulating intestinal fed state conditions with and without lipolysis products.

Authors:  Dimitrios G Fatouros; Isabelle Walrand; Bjorn Bergenstahl; Anette Müllertz
Journal:  Pharm Res       Date:  2008-11-12       Impact factor: 4.200

Review 4.  Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance.

Authors:  Angel Tan; Shasha Rao; Clive A Prestidge
Journal:  Pharm Res       Date:  2013-06-18       Impact factor: 4.200

5.  Self-assembled structures formed during lipid digestion: characterization and implications for oral lipid-based drug delivery systems.

Authors:  Stephanie Phan; Stefan Salentinig; Clive A Prestidge; Ben J Boyd
Journal:  Drug Deliv Transl Res       Date:  2014-06       Impact factor: 4.617

6.  Inclusion of Digestible Surfactants in Solid SMEDDS Formulation Removes Lag Time and Influences the Formation of Structured Particles During Digestion.

Authors:  Kapilkumar Vithani; Adrian Hawley; Vincent Jannin; Colin Pouton; Ben J Boyd
Journal:  AAPS J       Date:  2017-01-23       Impact factor: 4.009

7.  Insights into drug precipitation kinetics during in vitro digestion of a lipid-based drug delivery system using in-line raman spectroscopy and mathematical modeling.

Authors:  Cordula Stillhart; Georgios Imanidis; Martin Kuentz
Journal:  Pharm Res       Date:  2013-02-28       Impact factor: 4.200

8.  Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation.

Authors:  Christopher J H Porter; Ann Marie Kaukonen; Ben J Boyd; Glenn A Edwards; William N Charman
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

9.  Insertion and partition of sodium taurocholate into egg phosphatidylcholine vesicles.

Authors:  Karine Andrieux; Laura Forte; Sylviane Lesieur; Maité Paternostre; Michel Ollivon; Cécile Grabielle-Madelmont
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

10.  Liquid proliposomes of nimodipine drug delivery system: preparation, characterization, and pharmacokinetics.

Authors:  Chuandi Sun; Ji Wang; Jianping Liu; Lu Qiu; Wenli Zhang; Lei Zhang
Journal:  AAPS PharmSciTech       Date:  2013-01-15       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.